GenMark Diagnostics (GNMK) Reports In-Line Q3 EPS

GenMark Diagnostics (NASDAQ: GNMK) reported Q3 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.28 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
• The LGL Group (LGL) Misses Q2 EPS by 8c